Skip to main content
Fig. 6 | Biomaterials Research

Fig. 6

From: Nonviral delivery systems for antisense oligonucleotide therapeutics

Fig. 6

Copyright © 2021 The Authors. Advanced Science published by Wiley‐VCH GmbH)

The ASOs bound to the cationic material can be made available for cell uptake, and then apoptotic vesicles containing ASOs can be directly produced by cell induction of cells after uptake of the nucleic acid drug. Schematic diagram of the protocol for producing small apoptotic bodies and delivering ASOs into the brain. (Reprinted with permission from Ref [142].

Back to article page